Baillie Gifford & CO Glaukos Corp Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$34.86 - $63.77 $1,220 - $2,231	35 Added 14.96%	269 $12,000
Q1 2022 May 05, 2022	SELL	$44.33 - $57.82 $451,013 - $588,260	-10,174 Reduced 97.75%	234 $14,000
Q4 2021 Jan 20, 2022	SELL	$40.27 - $56.99 $80.9 Million - $115 Million	-2,009,917 Reduced 99.48%	10,408 $463,000
Q3 2021 Oct 19, 2021	SELL	$47.43 - $84.23 $170 Million - $302 Million	-3,581,371 Reduced 63.93%	2,020,325 $97.3 Million
Q2 2021 Aug 02, 2021	SELL	$73.06 - $97.7 $27.5 Million - $36.7 Million	-375,880 Reduced 6.29%	5,601,696 $475 Million
Q1 2021 May 06, 2021	BUY	$70.43 - $97.42 $78.4 Million - $108 Million	1,113,052 Added 22.88%	5,977,576 $502 Million
Q4 2020 Feb 10, 2021	BUY	$48.9 - $75.26 $23.5 Million - $36.1 Million	479,628 Added 10.94%	4,864,524 $366 Million
Q3 2020 Nov 12, 2020	BUY	$37.23 - $50.97 $13.4 Million - $18.3 Million	359,389 Added 8.93%	4,384,896 $217 Million
Q2 2020 Aug 12, 2020	BUY	$28.78 - $46.83 $11 Million - $17.9 Million	381,755 Added 10.48%	4,025,507 $155 Million
Q1 2020 May 08, 2020	BUY	$25.53 - $70.14 $1.7 Million - $4.68 Million	66,683 Added 1.86%	3,643,752 $112 Million
Q4 2019 Feb 10, 2020	BUY	$54.18 - $65.64 $40.7 Million - $49.3 Million	750,479 Added 26.55%	3,577,069 $195 Million
Q3 2019 Nov 07, 2019	BUY	$58.58 - $83.91 $88,221 - $126,368	1,506 Added 0.05%	2,826,590 $177 Million
Q2 2019 Aug 08, 2019	BUY	$63.59 - $78.71 $67.8 Million - $83.9 Million	1,065,462 Added 60.55%	2,825,084 $213 Million
Q1 2019 May 01, 2019	BUY	$50.75 - $80.54 $1.73 Million - $2.75 Million	34,139 Added 1.98%	1,759,622 $0
Q4 2018 Feb 14, 2019	BUY	$52.18 - $67.93 $19.5 Million - $25.4 Million	373,952 Added 27.67%	1,725,483 $96.9 Million
Q3 2018 Nov 13, 2018	BUY	$38.13 - $68.37 $5.33 Million - $9.56 Million	139,868 Added 11.54%	1,351,531 $87.7 Million
Q2 2018 Jul 17, 2018	BUY	$27.62 - $44.51 $2.54 Million - $4.1 Million	92,050 Added 8.22%	1,211,663 $49.2 Million
Q1 2018 May 10, 2018	BUY	$26.05 - $34.5 $3.89 Million - $5.15 Million	149,334 Added 15.39%	1,119,613 $34.5 Million
Q4 2017 Feb 13, 2018	BUY	$24.5 - $36.01 $23.8 Million - $34.9 Million	970,279	970,279 $24.9 Million

Others Institutions Holding GKOS

# of Institutions

341

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

Black Rock Inc. New York, NY

8.04M
Shares

$1.21 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

5.87M
Shares

$886 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

2.18M
Shares

$329 Million
0.05% of portfolio
State Street Corp Boston, MA

1.95M
Shares

$295 Million
0.01% of portfolio
Ameriprise Financial Inc Minneapolis, MN

1.64M
Shares

$247 Million
0.06% of portfolio

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account